What is the maximum recommended dose of metoprolol (metoprolol succinate) for a patient?

Maximum Metoprolol Succinate Dose

The maximum recommended dose of metoprolol succinate is 400 mg once daily for hypertension and atrial fibrillation rate control, while the target dose for heart failure is 200 mg once daily. 1, 2

Condition-Specific Maximum Doses

Heart Failure with Reduced Ejection Fraction

• Target dose: 200 mg once daily 2, 3
• Initial dose: 12.5-25 mg once daily 2, 3
• Titration: Double the dose every 1-2 weeks if well tolerated 1, 2
• The MERIT-HF trial demonstrated 34% reduction in all-cause mortality at the 200 mg daily target dose 3

Hypertension

• Maximum dose: 400 mg once daily 1, 2
• Initial dose: 50 mg once daily 1, 2
• Titration interval: Every 1-2 weeks based on blood pressure response 1, 2

Atrial Fibrillation Rate Control

• Maximum dose: 400 mg once daily 2
• Initial dose: 50 mg once daily 2
• Target resting heart rate: 50-80 bpm 2

Angina Pectoris

• Target dose: 200 mg once daily 2
• Titration: Gradually every 1-2 weeks as tolerated 2

Intravenous Administration

• Maximum total IV dose: 15 mg (administered as three 5 mg boluses given 5 minutes apart) 2
• Each bolus: 5 mg IV over 1-2 minutes 2
• Repeat dosing: Every 5 minutes as needed based on hemodynamic response 2

Critical Contraindications at Any Dose

Metoprolol should not be administered regardless of dose in patients with: 2

• Signs of heart failure, low output state, or decompensated heart failure 2
• Second or third-degree AV block without a functioning pacemaker 2
• Active asthma or severe reactive airway disease 2
• Symptomatic bradycardia (heart rate <50-60 bpm with symptoms) 2
• Systolic blood pressure <100 mmHg with symptoms 2

Pharmacokinetic Considerations

• Metoprolol succinate extended-release delivers metoprolol at a near constant rate for approximately 20 hours 4
• Once-daily dosing of 12.5-200 mg produces even plasma concentrations over 24 hours without marked peaks and troughs 4
• This formulation maintains consistent beta1-blockade and cardioselectivity at doses up to 200 mg daily 4

Special Population Considerations

Women

• Women may achieve optimal outcomes at 50% of guideline-recommended doses 2
• Metoprolol exposure is 50-80% higher in women than men 2
• A 50% dose reduction is recommended on average in women to reduce adverse drug reactions while maintaining efficacy 2
• For elderly women, 25 mg produces similar drug exposure to 100 mg in healthy young men 2

Chinese Patients with Stable Angina

• The 190 mg dose was superior to 95 mg for heart rate control in Chinese patients with stable angina 5
• Both doses were well tolerated with minimal discontinuation due to hypotension or bradycardia 5

Common Pitfalls to Avoid

• Never administer the full 15 mg IV dose as a single rapid bolus - this significantly increases hypotension and bradycardia risk 2
• Do not withhold beta-blockers until target doses of ACE inhibitors are achieved - metoprolol provides consistent benefit regardless of ACE inhibitor dose 6
• Avoid abrupt discontinuation - this can cause severe exacerbation of angina, myocardial infarction, ventricular arrhythmias, and increased mortality 2
• Do not assume clinical stability obviates the need for target dosing - even with symptom relief, the underlying disease continues to progress without adequate dosing 1

Dose-Response Relationship

• Studies support a dose-response relationship, meaning higher doses (up to target) provide greater mortality and morbidity reduction 2
• At least 50% of target dose (100 mg daily for heart failure) should be achieved for optimal outcomes 2
• However, evidence-based comparative judgments cannot be made between subtarget doses (e.g., whether 100 mg is superior to 50 mg) 1